ADS Diagnostics (BOM:523031) Cyclically Adjusted Revenue per Share: ₹72.71 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is ADS Diagnostics Cyclically Adjusted Revenue per Share?

ADS Diagnostics BOM:523031 Cyclically Adjusted Revenue per Share is ₹72.71 as of Jun. 2026. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

ADS Diagnostics's adjusted revenue per share for the three months ended in Jun. 2026 was ₹15.287. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹72.71 for the trailing ten years ended in Jun. 2026.

During the past 12 months, ADS Diagnostics's average Cyclically Adjusted Revenue Growth Rate was 10.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of ADS Diagnostics was 10.70% per year. The lowest was 9.40% per year. And the median was 10.10% per year.

As of today (2026-08-31), ADS Diagnostics's current stock price is ₹11.34. ADS Diagnostics's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹72.71. ADS Diagnostics's Cyclically Adjusted PS Ratio of today is 0.16.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ADS Diagnostics was 0.26. The lowest was 0.16. And the median was 0.20.


ADS Diagnostics  (BOM:523031) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

ADS Diagnostics's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=11.34/72.71
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ADS Diagnostics was 0.26. The lowest was 0.16. And the median was 0.20.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


ADS Diagnostics Cyclically Adjusted Revenue per Share Related Terms


ADS Diagnostics Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for ADS Diagnostics's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ADS Diagnostics Cyclically Adjusted Revenue per Share Chart

ADS Diagnostics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.65 54.16 61.46 65.01 72.25

ADS Diagnostics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.83 70.41 72.10 72.25 72.71

BOM:523031 vs OZSC, WHSI, LENSF: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, ADS Diagnostics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ADS Diagnostics Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ADS Diagnostics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where ADS Diagnostics's Cyclically Adjusted PS Ratio falls into.



ADS Diagnostics Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ADS Diagnostics's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=15.287/167.3573*167.3573
=15.287

Current CPI (Jun. 2026) = 167.3573.

ADS Diagnostics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 4.231 105.961 6.683
201612 3.209 105.196 5.105
201703 1.665 105.196 2.649
201706 11.433 107.109 17.864
201709 4.252 109.021 6.527
201712 2.916 109.404 4.461
201803 10.333 109.786 15.752
201806 5.497 111.317 8.264
201809 14.320 115.142 20.814
201812 6.723 115.142 9.772
201903 14.319 118.202 20.274
201906 18.964 120.880 26.256
201909 24.143 123.175 32.803
201912 6.694 126.235 8.875
202003 11.849 124.705 15.902
202006 6.076 127.000 8.007
202009 2.677 130.118 3.443
202012 17.132 130.889 21.905
202103 16.897 131.771 21.460
202106 6.636 134.084 8.283
202109 9.129 135.847 11.247
202112 19.278 138.161 23.352
202203 11.614 138.822 14.001
202206 9.118 142.347 10.720
202209 10.445 144.661 12.084
202212 16.792 145.763 19.280
202303 24.262 146.865 27.647
202306 14.977 150.280 16.679
202309 32.953 151.492 36.404
202312 32.323 152.924 35.374
202403 26.998 153.035 29.525
202406 18.847 155.789 20.247
202409 27.030 157.882 28.652
202412 11.833 158.323 12.508
202503 15.053 157.552 15.990
202506 19.359 159.755 20.280
202509 66.753 162.289 68.838
202512 24.666 163.281 25.282
202603 18.229 164.272 18.571
202606 15.287 167.357 15.287

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹72.71 mean?
ADS Diagnostics (BOM:523031) has a Cyclically Adjusted Revenue per Share of ₹72.71 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on ADS Diagnostics and its competitors.
Is ADS Diagnostics' Cyclically Adjusted Revenue per Share too high?
ADS Diagnostics' current Cyclically Adjusted Revenue per Share is ₹72.71.
How does ADS Diagnostics' Cyclically Adjusted Revenue per Share compare to OZSC and WHSI?
ADS Diagnostics' Cyclically Adjusted Revenue per Share of ₹72.71 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on ADS Diagnostics and its competitors. ADS Diagnostics's current Cyclically Adjusted Revenue per Share is ₹72.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ADS Diagnostics stock overvalued right now?
ADS Diagnostics (BOM:523031) has a current Cyclically Adjusted Revenue per Share of ₹72.71. The stock's GF Value™ is ₹11.48, compared to a current price of ₹11.34 — trading 1.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹72.71. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For ADS Diagnostics (BOM:523031), the current Cyclically Adjusted Revenue per Share is ₹72.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ADS Diagnostics Business Description

Address 114, Sant Nagar, East of Kailash, New Delhi, IND, 110065
ADS Diagnostics Ltd is an India-based company engaged in the sale of medical equipment. It is focused on the business activity of the sale of trading goods, servicing and installation of medical equipment, lease rental, and distribution. The company generates key revenue from the sale of trading goods. It sells its products and services in India and internationally.